Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs.

G Nichol, A Nix, P J Barnes, K F Chung

Department of Thoracic Medicine, National Heart and Lung Institute, London.

The effect of inhaled prostaglandin (PG) F2 alpha on the response to the inhaled tussive agent capsaicin was investigated in normal subjects. Seven subjects inhaled three breaths of four doses of capsaicin (0.3, 0.6, 1.2, and 2.4 nmol) before and immediately after inhaling PGF2 alpha (0.1 mumol) or placebo (0.15M NaCl) on separate days. The numbers of capsaicin induced coughs were greater after PGF2 alpha (mean 42.3 coughs) than after 0.15M sodium chloride (30.1). Visual analogue scores (0-10 on a 10 cm continuous scale) showed that capsaicin was more irritant after PGF2 alpha than after saline. Total respiratory resistance (Rrs), measured by the forced oscillation technique, was unaltered throughout the study. A double blind, placebo controlled study of the effects of inhaled salbutamol (200 micrograms, 0.6 mumol) and ipratropium bromide (40 micrograms, 0.1 mumol) on cough induced by capsaicin (2.4 nmol) and by PGF2 alpha (0.1 mumol) and on PGF2 alpha augmented, capsaicin induced coughing was performed in seven subjects. Neither drug had any effect on capsaicin induced coughing. Salbutamol reduced coughing due to PGF2 alpha (mean 7.7 coughs after salbutamol, 9.3 after placebo) but ipratropium bromide did not (mean 6.9 coughs after ipratropium bromide, 6.6 after placebo). Salbutamol also inhibited the augmentation of the capsaicin induced cough that followed inhalation of PGF2 alpha (mean augmentation 1.9 coughs after salbutamol, 4.1 after placebo), whereas ipratropium bromide did not (augmentation 1.7 coughs after ipratropium bromide, 2.7 after placebo). No changes in Rrs were seen after PGF2 alpha or either drug. Thus salbutamol reduces PGF2 alpha induced cough and the augmentation of capsaicin induced cough that follows PGF2 alpha.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Fahim, A., Morice, A. H. (2009). Heightened Cough Sensitivity Secondary to Latanoprost. Chest 136: 1406-1407 [Abstract] [Full Text]  
• Chung, K. (2007). Review Series: Chronic cough: Future directions in chronic cough: mechanisms and antitussives. Chronic Respiratory Disease 4: 159-165 [Abstract]  
• Prudon, B., Birring, S. S., Vara, D. D., Hall, A. P., Thompson, J. P., Pavord, I. D. (2005). Cough and Glottic-Stop Reflex Sensitivity in Health and Disease. Chest 127: 550-557 [Abstract] [Full Text]  
• Barnes, P. J. (2004). Distribution of Receptor Targets in the Lung. Proc Am Thorac Soc 1: 345-351 [Abstract] [Full Text]  
• Barnes, P. J. (2004). Mediators of Chronic Obstructive Pulmonary Disease. Pharmacol. Rev. 56: 515-548 [Abstract] [Full Text]  
• Li, A M, Lex, C, Zacharasiewicz, A, Wong, E, Erin, E, Hansel, T, Wilson, N M, Bush, A (2003). Cough frequency in children with stable asthma: correlation with lung function, exhaled nitric oxide, and sputum eosinophil count. Thorax 58: 974-978 [Abstract] [Full Text]  
• Bowles, W.R., Flores, C.M., Jackson, D.L., Hargreaves, K.M. (2003). {beta}2-Adrenoceptor Regulation of CGRP Release from Capsaicin-sensitive Neurons. JDR 82: 308-311 [Abstract] [Full Text]  
• Barnes, P.J. (2002). Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids. Eur Respir J 19: 182-191 [Abstract] [Full Text]  
• Doherty, M J, Mister, R, Pearson, M G, Calverley, P M A (2000). Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 55: 643-649 [Abstract] [Full Text]  
• Jatakanon, A., Lalloo, U. G, Lim, S., Chung, K. F., Barnes, P. J (1999). Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 54: 234-237 [Abstract] [Full Text]